about
Structural Analysis of Charge Discrimination in the Binding of Inhibitors to Human Carbonic Anhydrases I and IIRecent advances in pharmacotherapy of glaucomaAn evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.Latanoprost in the treatment of glaucoma.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Short- and long-term safety of glaucoma drugs.
@ast
Short- and long-term safety of glaucoma drugs.
@en
type
label
Short- and long-term safety of glaucoma drugs.
@ast
Short- and long-term safety of glaucoma drugs.
@en
prefLabel
Short- and long-term safety of glaucoma drugs.
@ast
Short- and long-term safety of glaucoma drugs.
@en
P2860
P356
P1476
Short- and long-term safety of glaucoma drugs
@en
P2093
Joel S Schuman
P2860
P304
P356
10.1517/14740338.1.2.181
P407
P577
2002-07-01T00:00:00Z